CN111333591A - A kind of preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone - Google Patents
A kind of preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone Download PDFInfo
- Publication number
- CN111333591A CN111333591A CN202010315236.XA CN202010315236A CN111333591A CN 111333591 A CN111333591 A CN 111333591A CN 202010315236 A CN202010315236 A CN 202010315236A CN 111333591 A CN111333591 A CN 111333591A
- Authority
- CN
- China
- Prior art keywords
- morpholine
- propanol
- reaction
- preparation
- hydrazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000126 substance Substances 0.000 claims abstract description 25
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 14
- 239000003054 catalyst Substances 0.000 claims abstract description 12
- TVHAMVOINIHMEX-UHFFFAOYSA-N 3-amino-5-morpholinomethyl-2-oxazolidinone Chemical compound O1C(=O)N(N)CC1CN1CCOCC1 TVHAMVOINIHMEX-UHFFFAOYSA-N 0.000 claims abstract description 6
- PJDIQYBDWFEFRO-UHFFFAOYSA-N N1(CCOCC1)CC1CNC(O1)=O.NN Chemical compound N1(CCOCC1)CC1CNC(O1)=O.NN PJDIQYBDWFEFRO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims abstract description 6
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims abstract description 4
- VUPKGFBOKBGHFZ-UHFFFAOYSA-N dipropyl carbonate Chemical compound CCCOC(=O)OCCC VUPKGFBOKBGHFZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- ODCCJTMPMUFERV-UHFFFAOYSA-N ditert-butyl carbonate Chemical compound CC(C)(C)OC(=O)OC(C)(C)C ODCCJTMPMUFERV-UHFFFAOYSA-N 0.000 claims abstract description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 54
- 238000006243 chemical reaction Methods 0.000 claims description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- -1 hydrazine-5-morpholinyl methyl-2-oxazolidinone Chemical compound 0.000 claims description 34
- 239000002585 base Substances 0.000 claims description 29
- 239000002904 solvent Substances 0.000 claims description 28
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 22
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 20
- 229910052744 lithium Inorganic materials 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 claims description 13
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 238000007142 ring opening reaction Methods 0.000 claims description 12
- 230000001476 alcoholic effect Effects 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 8
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 238000000895 extractive distillation Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 17
- 230000015572 biosynthetic process Effects 0.000 abstract description 15
- 238000005580 one pot reaction Methods 0.000 abstract description 6
- 238000011084 recovery Methods 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- KIHQZLPHVZKELA-UHFFFAOYSA-N 1,3-dibromopropan-2-ol Chemical compound BrCC(O)CBr KIHQZLPHVZKELA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229940051269 1,3-dichloro-2-propanol Drugs 0.000 description 1
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 description 1
- YVQVOQKFMFRVGR-VGOFMYFVSA-N 5-(morpholin-4-ylmethyl)-3-[(e)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OC(CN2CCOCC2)C1 YVQVOQKFMFRVGR-VGOFMYFVSA-N 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229950000337 furaltadone Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000011140 intestinal infectious disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
本发明提供了一种3‑肼‑5‑吗啉基甲基‑2‑恶唑烷酮的制备方法,属于化学合成技术领域。该制备方法包括:将1‑Boc保护肼‑3‑吗啉‑2‑丙醇与碳酸酯类物质进行合环反应,得到3‑Boc保护肼‑5‑吗啉基甲基‑2‑恶唑烷酮,最后水解得到AMOZ。其中,1‑Boc保护肼‑3‑吗啉‑2‑丙醇的化学结构式为
3‑Boc肼‑5‑吗啉基甲基‑2‑恶唑烷酮的化学结构式为AMOZ的化学结构式为碳酸酯类物质包括碳酸二乙酯、碳酸二甲酯、碳酸二叔丁酯及碳酸二丙酯中的至少一种。上述方法合成路线简单,采用一锅法合成AMOZ并在制备过程中使用催化剂,极大减少了合成过程的损失,合成产率及回收率较高,适于大量生产。The invention provides a preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone, belonging to the technical field of chemical synthesis. The preparation method comprises: subjecting 1-Boc-protected hydrazine-3-morpholine-2-propanol to a ring-closure reaction with carbonates to obtain 3-Boc-protected hydrazine-5-morpholinomethyl-2-oxazole Alkanone, and finally hydrolyzed to obtain AMOZ. Wherein, the chemical structural formula of 1-Boc protected hydrazine-3-morpholine-2-propanol is
The chemical structural formula of 3-Boc hydrazine-5-morpholinomethyl-2-oxazolidinone is The chemical structural formula of AMOZ is The carbonates include at least one of diethyl carbonate, dimethyl carbonate, di-tert-butyl carbonate and dipropyl carbonate. The above-mentioned method has a simple synthesis route, adopts a one-pot method to synthesize AMOZ and uses a catalyst in the preparation process, which greatly reduces the loss of the synthesis process, and the synthesis yield and recovery rate are high, which is suitable for mass production.Description
技术领域technical field
本发明涉及化学合成技术领域,具体而言,涉及一种3-肼-5-吗啉基甲基-2-恶唑烷酮的制备方法。The invention relates to the technical field of chemical synthesis, in particular to a preparation method of 3-hydrazine-5-morpholinomethyl-2-oxazolidinone.
背景技术Background technique
3-肼-5-吗啉基甲基-2-恶唑烷酮(AMOZ),是一种硝基呋喃类药物-呋喃它酮(Furaltadone)的代谢物。通过对细菌体内的氧化还原酶造成干扰,破坏细菌的正常代谢,使整个代谢系统混乱,从而起到杀菌的作用。呋喃它酮的药物抗菌谱交广,对大多数革兰氏阳性菌、阴性菌均可以起到抗菌作用。3-hydrazine-5-morpholinomethyl-2-oxazolidinone (AMOZ) is a metabolite of a nitrofuran drug, Furaltadone. By interfering with the oxidoreductase in the bacteria, it destroys the normal metabolism of the bacteria and makes the entire metabolic system chaotic, thereby playing a role in sterilization. The antibacterial spectrum of furanotadone is broad, and it can play an antibacterial effect on most Gram-positive and negative bacteria.
由于呋喃它酮具有非常好的抗菌作用,因此在临床上主要用于鸡白痢、鸡大肠杆菌病、鸡球虫病等各种肠道感染性疾病的治疗及用作猪、禽类和水产促生长的添加剂。Because furanotazone has very good antibacterial effect, it is mainly used clinically for the treatment of various intestinal infectious diseases such as pullorum, chicken colibacillosis, chicken coccidiosis, and for promoting the growth of pigs, poultry and aquatic products. of additives.
目前合成AMOZ的方法合成产率低,回收率差。因此,开发一种全新合成AMOZ的方法具有重要意义。The current method for synthesizing AMOZ has low synthetic yield and poor recovery. Therefore, it is of great significance to develop a new method for synthesizing AMOZ.
发明内容SUMMARY OF THE INVENTION
本发明的目的包括提供一种AMOZ的制备方法,该方法合成路线简单,采用一锅法合成硝基呋喃代谢物AMOZ并通过在制备过程中使用催化剂,极大减少了合成过程的损失,合成产率及回收率较高,适于大量生产。The objects of the present invention include providing a preparation method of AMOZ, the method has a simple synthetic route, adopts a one-pot method to synthesize the nitrofuran metabolite AMOZ, and uses a catalyst in the preparation process, which greatly reduces the loss of the synthesis process, and the synthetic product High yield and recovery rate, suitable for mass production.
本发明解决其技术问题是采用以下技术方案来实现的:The present invention solves its technical problem by adopting the following technical solutions to realize:
本发明提出一种AMOZ的制备方法,包括以下步骤:将1-Boc肼-3-吗啉-2-丙醇与碳酸酯类物质进行合环反应,得到3-Boc肼-5-吗啉基甲基-2-恶唑烷酮,最后水解得到最终产物AMOZ。The present invention provides a method for preparing AMOZ, which comprises the following steps: subjecting 1-Boc hydrazine-3-morpholine-2-propanol to a ring-closing reaction with carbonate substances to obtain 3-Boc hydrazine-5-morpholinyl Methyl-2-oxazolidinone, and finally hydrolyzed to obtain the final product AMOZ.
其中,1-Boc肼-3-吗啉-2-丙醇的化学结构式为3-Boc肼-5-吗啉基甲基-2-恶唑烷酮的化学结构式为AMOZ的化学结构式为:碳酸酯类物质包括碳酸二乙酯、碳酸二甲酯、碳酸二叔丁酯以及碳酸二丙酯中的至少一种。Wherein, the chemical structural formula of 1-Boc hydrazine-3-morpholine-2-propanol is The chemical structural formula of 3-Boc hydrazine-5-morpholinomethyl-2-oxazolidinone is The chemical structural formula of AMOZ is: The carbonates include at least one of diethyl carbonate, dimethyl carbonate, di-tert-butyl carbonate and dipropyl carbonate.
该合成路线简单,采用一锅法合成,减少了大量的中间的纯化步骤,有利于提高产率。The synthetic route is simple, adopts one-pot synthesis, reduces a large number of intermediate purification steps, and is beneficial to improve the yield.
在一些可选地实施方案中,合环反应是在碱性催化剂存在的条件下进行。在制备过程中使用催化剂,极大减少了合成过程的损失,合成产率及回收率较高。In some alternative embodiments, the ring closure reaction is carried out in the presence of a basic catalyst. The catalyst is used in the preparation process, which greatly reduces the loss of the synthesis process, and the synthesis yield and recovery rate are high.
在一些可选地实施方案中,合环反应于30-100℃的条件下进行2-7h;优选于60℃的条件下进行4h。In some optional embodiments, the ring-closing reaction is carried out at 30-100°C for 2-7h; preferably at 60°C for 4h.
在一些优选地实施方案中,合环反应是于30-100℃的条件下将碱性催化剂加入至1-Boc肼-3-吗啉-2-丙醇与碳酸二乙酯的反应体系中进行2-7h。In some preferred embodiments, the ring-closure reaction is carried out by adding a basic catalyst to the reaction system of 1-Boc hydrazine-3-morpholine-2-propanol and diethyl carbonate at a temperature of 30-100° C. 2-7h.
在一些可选地实施方案中,碱性催化剂包括NaOH、KOH、Na2CO3和甲醇钠中的至少一种。In some alternative embodiments, the basic catalyst includes at least one of NaOH , KOH, Na2CO3 , and sodium methoxide.
在一些可选地实施方案中,1-Boc肼-3-吗啉-2-丙醇与碳酸二乙酯的摩尔比为1:0.8-3,优选为1:1.5。In some optional embodiments, the molar ratio of 1-Boc hydrazine-3-morpholine-2-propanol to diethyl carbonate is 1:0.8-3, preferably 1:1.5.
在一些可选地实施方案中,在与碳酸二乙酯混合前,先将1-Boc肼-3-吗啉-2-丙醇与第一溶剂复溶,优选地,第一溶剂包括四氢呋喃。In some alternative embodiments, 1-Boc hydrazine-3-morpholine-2-propanol is reconstituted with a first solvent, preferably, the first solvent comprises tetrahydrofuran, prior to mixing with diethyl carbonate.
进一步地,1-Boc肼-3-吗啉-2-丙醇的制备方法包括:将1-吗啉-2,3-环氧丙烷与Boc保护的肼进行开环反应,1-吗啉-2,3-环氧丙烷的化学结构式为 Further, the preparation method of 1-Boc hydrazine-3-morpholine-2-propanol comprises: performing a ring-opening reaction between 1-morpholine-2,3-epoxypropane and Boc-protected hydrazine, 1-morpholine- The chemical structural formula of 2,3-propylene oxide is
在一些优选的实施方案中,开环反应在醇试剂或呋喃类化合物存在的条件下进行。In some preferred embodiments, the ring-opening reaction is carried out in the presence of an alcohol reagent or a furanic compound.
在一些可选地实施方案中,醇试剂包括乙醇或甲醇;呋喃类化合物包括四氢呋喃。In some optional embodiments, the alcohol reagent includes ethanol or methanol; the furanic compound includes tetrahydrofuran.
在一些可选地实施方案中,1-吗啉-2,3-环氧丙烷与肼的摩尔比为1:1-10,优选为1:5。In some alternative embodiments, the molar ratio of 1-morpholine-2,3-epoxypropane to hydrazine is 1:1-10, preferably 1:5.
进一步地,开环反应是于15-30℃的条件下进行2-6h;更优地,于25℃的条件下进行4h。Further, the ring-opening reaction is carried out under the condition of 15-30°C for 2-6h; more preferably, under the condition of 25°C for 4h.
在一些可选地实施方案中,开环反应结束后,还包括除去剩余的Boc保护的肼和溶剂,更优地,采用有机溶剂萃取蒸馏的方法除去Boc保护的肼和溶剂。In some optional embodiments, after the end of the ring-opening reaction, it also includes removing the remaining Boc-protected hydrazine and solvent, more preferably, removing the Boc-protected hydrazine and solvent by using an organic solvent extractive distillation method.
进一步地,1-吗啉-2,3-环氧丙烷的制备方法包括:将1-卤代-3-吗啉-2-丙醇与碱反应,1-卤代-3-吗啉-2-丙醇的化学结构式为1-卤代-3-吗啉-2-丙醇中的卤素X为溴或者氯。Further, the preparation method of 1-morpholine-2,3-epoxypropane comprises: reacting 1-halo-3-morpholine-2-propanol with a base, 1-halo-3-morpholine-2 - The chemical structural formula of propanol is Halogen X in 1-halo-3-morpholine-2-propanol is bromine or chlorine.
在一些可选的实施方案中,1-卤代-3-吗啉-2-丙醇与碱在第二溶剂存在的条件下进行,优选地,第二溶剂包括四氢呋喃。In some alternative embodiments, the 1-halo-3-morpholine-2-propanol and base are carried out in the presence of a second solvent, preferably, the second solvent includes tetrahydrofuran.
在一些可选地实施方案中,1-卤代-3-吗啉-2-丙醇与碱的摩尔比为1:1-5,更优为1:3。In some alternative embodiments, the molar ratio of 1-halo-3-morpholine-2-propanol to base is 1:1-5, more preferably 1:3.
进一步地,1-卤代-3-吗啉-2-丙醇与碱是于15-60℃的条件下反应1-5h,优选地于40℃的条件下反应4h。Further, the 1-halo-3-morpholine-2-propanol and the base are reacted at 15-60° C. for 1-5 hours, preferably at 40° C. for 4 hours.
在一些可选地实施方案中,碱包括NaOH、KOH、Na2CO3、乙醇钠和叔丁醇钠中的至少一种。In some alternative embodiments, the base includes at least one of NaOH , KOH, Na2CO3 , sodium ethoxide, and sodium tert-butoxide.
在一些可选地实施方案中,1-卤代-3-吗啉-2-丙醇与碱反应结束后,还包括除去剩余的有机溶剂,优选地,采用蒸馏方式除去有机溶剂。In some optional embodiments, after the reaction between 1-halo-3-morpholine-2-propanol and the base is completed, it also includes removing the remaining organic solvent, preferably, removing the organic solvent by distillation.
进一步地,1-卤代-3-吗啉-2-丙醇的制备方法包括:将1,3-二卤代-2-丙醇与碱反应,随后再与吗啉进行SN2反应,1,3-二卤代-2-丙醇的化学结构式为卤代为溴代或者氯代。Further, the preparation method of 1-halo-3-morpholine-2-propanol comprises: reacting 1,3-dihalo-2-propanol with a base, and then performing S N2 reaction with morpholine, 1 , The chemical structural formula of 3-dihalo-2-propanol is Halogen is bromo or chloro.
在一些可选地实施方案中,将1,3-二卤代-2-丙醇与碱混合于第一醇溶液中进行加热反应,随后加入溶解有吗啉的第二醇溶液进行SN2反应。In some optional embodiments, 1,3-dihalo-2-propanol is mixed with a base in a first alcohol solution for heating reaction, and then a second alcohol solution in which morpholine is dissolved is added for S N2 reaction .
在一些可选地实施方案中,将1,3-二卤代-2-丙醇溶解于第一醇溶液中,随后再加入碱进行加热反应。In some alternative embodiments, 1,3-dihalo-2-propanol is dissolved in the first alcohol solution, followed by addition of a base for heating reaction.
在一些可选地实施方案中,1,3-二卤代-2-丙醇与碱的摩尔比为1:2-5,优选为1:3.5。In some alternative embodiments, the molar ratio of 1,3-dihalo-2-propanol to base is 1:2-5, preferably 1:3.5.
在一些可选地实施方案中,第一醇溶液包括甲醇溶液,第二醇溶液包括乙醇溶液。In some alternative embodiments, the first alcoholic solution includes methanol solution and the second alcoholic solution includes ethanol solution.
在一些可选地实施方案中,加热反应于15-60℃的条件下进行1-6h,优选于50℃的条件下反应3h。In some optional embodiments, the heating reaction is carried out at 15-60 °C for 1-6 h, preferably at 50 °C for 3 h.
进一步地,1,3-二氯-2-丙醇与吗啉的摩尔比为1:1-5,优选为1:3。Further, the molar ratio of 1,3-dichloro-2-propanol to morpholine is 1:1-5, preferably 1:3.
在一些可选地实施方案中,SN2反应于15-60℃的条件下进行2-10h,优选于40℃的条件下反应3h。In some optional embodiments, the Sn2 reaction is carried out at 15-60°C for 2-10 hours, preferably at 40°C for 3 hours.
在一些可选地实施方案中,SN2反应完成后还包括除去剩余的第一醇溶液和第二醇溶液。In some optional embodiments, after the SN2 reaction is completed, it further includes removing the remaining first alcoholic solution and the second alcoholic solution.
进一步地,1,3-二卤代-2-丙醇的制备方法包括:将丙三醇与三氟乙酸酐、三(二甲胺基)膦(HMPT)和卤化锂类化合物在四氢呋喃溶剂下反应。Further, the preparation method of 1,3-dihalo-2-propanol comprises: mixing glycerol with trifluoroacetic anhydride, tris(dimethylamino)phosphine (HMPT) and lithium halide compounds in tetrahydrofuran solvent reaction.
在一些可选地实施方案中,卤化锂类化合物包括氯化锂或溴化锂中的至少一种。In some optional embodiments, the lithium halide compound includes at least one of lithium chloride or lithium bromide.
在一些可选地实施方案中,丙三醇与卤化锂类化合物的摩尔比为1:5-15,更优为1:10。In some optional embodiments, the molar ratio of glycerol to lithium halide compound is 1:5-15, more preferably 1:10.
进一步地,丙三醇置于油浴中,加入THF(四氢呋喃),随后再加入三氟乙酸酐、三(二甲胺基)膦和卤化锂。Further, glycerol was placed in an oil bath, THF (tetrahydrofuran) was added, followed by trifluoroacetic anhydride, tris(dimethylamino)phosphine and lithium halide.
在一些可选地实施方案中,丙三醇与三氟乙酸酐、三(二甲胺基)膦和卤化锂类化合物于50-100℃的条件下进行5-24h,优选地于80℃的条件下进行12h。In some optional embodiments, glycerol and trifluoroacetic anhydride, tris(dimethylamino)phosphine and lithium halide compounds are carried out at 50-100°C for 5-24h, preferably at 80°C Condition for 12h.
在一些可选地实施方案中,丙三醇与三氟乙酸酐、三(二甲胺基)膦和卤化锂类化合物反应完成后,还包括除去剩余的溶剂,更优地,采用减压蒸馏的方式除去溶剂。In some optional embodiments, after the completion of the reaction of glycerol with trifluoroacetic anhydride, tris(dimethylamino)phosphine and lithium halide compounds, it also includes removing the remaining solvent, more preferably, using vacuum distillation way to remove the solvent.
本申请提供的AMOZ的制备方法的有益效果包括:The beneficial effects of the preparation method of AMOZ provided by the application include:
本申请提供的AMOZ的制备方法操作简单,采用一锅法合成硝基呋喃代谢物AMOZ并通过在制备过程中使用保护基团,极大减少了合成过程的损失,合成产率及回收率较高。The preparation method of AMOZ provided by the present application is simple to operate, adopts a one-pot method to synthesize the nitrofuran metabolite AMOZ, and uses a protective group in the preparation process, which greatly reduces the loss of the synthesis process, and the synthesis yield and recovery rate are high .
附图说明Description of drawings
为了更清楚地说明本发明实施方式的技术方案,下面将对实施方式中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本发明的某些实施例,因此不应被看作是对范围的限定,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他相关的附图。In order to explain the technical solutions of the embodiments of the present invention more clearly, the following briefly introduces the accompanying drawings used in the embodiments. It should be understood that the following drawings only show some embodiments of the present invention, and therefore do not It should be regarded as a limitation of the scope, and for those of ordinary skill in the art, other related drawings can also be obtained according to these drawings without any creative effort.
图1为本申请实施例1提供的AMOZ的合成路线。Fig. 1 is the synthetic route of AMOZ that the
具体实施方式Detailed ways
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。In order to make the objectives, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not indicated in the examples, it is carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used without the manufacturer's indication are conventional products that can be purchased from the market.
下面对本申请实施例提供的3-肼-5-吗啉基甲基-2-恶唑烷酮(AMOZ)的制备方法进行具体说明。The preparation method of 3-hydrazine-5-morpholinomethyl-2-oxazolidinone (AMOZ) provided in the examples of the present application will be specifically described below.
本申请提供的AMOZ的化学式为: The chemical formula of AMOZ provided in this application is:
该物质的制备方法主要包括以下步骤:将1-Boc肼-3-吗啉-2-丙醇与碳酸酯类物质进行合环反应,得到3-Boc肼-5-吗啉基甲基-2-恶唑烷酮,最后水解得到最终产物AMOZ。其中,1-Boc肼-3-吗啉-2-丙醇的化学结构式为3-Boc肼-5-吗啉基甲基-2-恶唑烷酮的化学结构式为AMOZ的化学结构式为:碳酸酯类物质包括碳酸二乙酯、碳酸二甲酯、碳酸二叔丁酯以及碳酸二丙酯中的至少一种。The preparation method of the substance mainly includes the following steps: subjecting 1-Boc hydrazine-3-morpholine-2-propanol to a ring closure reaction with carbonate substances to obtain 3-Boc hydrazine-5-morpholinylmethyl-2 -Oxazolidinone, finally hydrolyzed to give the final product AMOZ. Wherein, the chemical structural formula of 1-Boc hydrazine-3-morpholine-2-propanol is The chemical structural formula of 3-Boc hydrazine-5-morpholinomethyl-2-oxazolidinone is The chemical structural formula of AMOZ is: The carbonates include at least one of diethyl carbonate, dimethyl carbonate, di-tert-butyl carbonate and dipropyl carbonate.
可参考地,在制备过程中1-Boc肼-3-吗啉-2-丙醇与碳酸二乙酯的摩尔比可以为1:0.8-3,如1:0.8、1:1、1:1.5、1:2、1:2.5或1:3等,也可以为1:0.8-3范围内的其它比值,优选为1:1.5。For reference, in the preparation process, the molar ratio of 1-Boc hydrazine-3-morpholine-2-propanol to diethyl carbonate may be 1:0.8-3, such as 1:0.8, 1:1, 1:1.5 , 1:2, 1:2.5 or 1:3, etc., or other ratios in the range of 1:0.8-3, preferably 1:1.5.
在一些可选地实施方案中,在与碳酸二乙酯混合前,可先将1-水合肼-3-吗啉-2-丙醇与第一溶剂复溶,其中,第一溶剂例如可以包括四氢呋喃。此外,第一溶剂还可以包括甲醇,氯仿,或者乙醇等。In some optional embodiments, before mixing with diethyl carbonate, 1-hydrazine hydrate-3-morpholine-2-propanol can be reconstituted with a first solvent, wherein, for example, the first solvent can include Tetrahydrofuran. In addition, the first solvent may also include methanol, chloroform, or ethanol or the like.
可参考地,上述的合环反应是在碱性催化剂存在的条件下进行。其中,碱性催化剂可以但不仅限于包括NaOH、KOH、Na2CO3和甲醇钠中的至少一种,优选为甲醇钠。For reference, the above-mentioned ring-closing reaction is carried out in the presence of a basic catalyst. Wherein, the basic catalyst may include, but is not limited to, at least one of NaOH, KOH, Na 2 CO 3 and sodium methoxide, preferably sodium methoxide.
在一些可选地实施方案中,合环反应是将碱性催化剂加入至1-Boc肼-3-吗啉-2-丙醇与碳酸二乙酯的反应体系中。In some optional embodiments, the ring closure reaction is to add a basic catalyst to the reaction system of 1-Boc hydrazine-3-morpholine-2-propanol and diethyl carbonate.
在一些优选地实施方案中,上述合环反应于30-100℃(如30℃、40℃、50℃、60℃、70℃、80℃、90℃或100℃等)的条件下进行2-7h(如2h、3h、4h、5h、6h或7h)。在一些更优选地实施方案中,上述合环反应于60℃的条件下进行4h。In some preferred embodiments, the above-mentioned ring-closing reaction is carried out under the conditions of 30-100°C (such as 30°C, 40°C, 50°C, 60°C, 70°C, 80°C, 90°C or 100°C, etc.) for 2- 7h (eg 2h, 3h, 4h, 5h, 6h or 7h). In some more preferred embodiments, the above ring-closing reaction is carried out at 60°C for 4h.
在一些具体的实施方式中,可以先将1-Boc肼-3-吗啉-2-丙醇加入至四氢呋喃中溶解,然后按配比将碳酸二乙酯加入至复溶溶液中,升温至60℃,随后将溶解于甲醇中的甲醇钠溶液加入至上述反应体系中,反应4h。In some specific embodiments, 1-Boc hydrazine-3-morpholine-2-propanol can be added to tetrahydrofuran to dissolve, and then diethyl carbonate is added to the reconstituted solution according to the proportion, and the temperature is raised to 60° C. , and then the sodium methoxide solution dissolved in methanol was added to the above reaction system, and the reaction was carried out for 4h.
可参照地,上述合成过程可表示为For reference, the above synthesis process can be expressed as
进一步地,1-Boc肼-3-吗啉-2-丙醇的制备方法可以包括:将1-吗啉-2,3-环氧丙烷与Boc保护的肼进行开环反应,1-吗啉-2,3-环氧丙烷的化学结构式为 Further, the preparation method of 1-Boc hydrazine-3-morpholine-2-propanol may include: ring-opening reaction of 1-morpholine-2,3-epoxypropane with Boc-protected hydrazine, 1-morpholine The chemical structural formula of -2,3-epoxypropane is
可参考地,上述开环反应于醇试剂或呋喃类化合物存在的条件下进行。其中,醇试剂包括乙醇或甲醇,呋喃类化合物包括四氢呋喃。For reference, the above-mentioned ring-opening reaction is carried out in the presence of an alcohol reagent or a furan compound. Wherein, the alcohol reagent includes ethanol or methanol, and the furan compound includes tetrahydrofuran.
可参考地,在制备过程中,1-吗啉-2,3-环氧丙烷与水合肼的摩尔比可以为1:1-10,如1:1、1:2、1:5、1:6、1:8或1:10等,也可以为1:1-10范围内的其它比值,优选为1:5。For reference, in the preparation process, the molar ratio of 1-morpholine-2,3-epoxypropane to hydrazine hydrate may be 1:1-10, such as 1:1, 1:2, 1:5, 1:1: 6, 1:8 or 1:10, etc., and other ratios in the range of 1:1-10, preferably 1:5.
在一些可选地实施方案中,开环反应可以是于15-30℃(如15℃、20℃、25℃或30℃等)的条件下进行2-6h(如2h、3h、4h、5h或6h等),优选于25℃的条件下进行4h。In some optional embodiments, the ring-opening reaction can be carried out at 15-30°C (eg, 15°C, 20°C, 25°C, or 30°C, etc.) for 2-6h (eg, 2h, 3h, 4h, 5h). or 6h, etc.), preferably at 25°C for 4h.
在一些可选地实施方案中,开环反应结束后,还包括除去剩余的Boc保护的肼和溶剂,例如可采用有机溶剂萃取蒸馏的方法除去Boc保护的肼和溶剂。In some optional embodiments, after the end of the ring-opening reaction, it also includes removing the remaining Boc-protected hydrazine and solvent, for example, the Boc-protected hydrazine and solvent can be removed by extractive distillation with an organic solvent.
在一具体的实施方式中,可以按配比将1-吗啉-2,3-环氧丙烷与Boc保护的肼分别置于冰水浴中,然后再分别加入乙醇,待温度降至0℃后,撤去冰水浴,待溶液恢复至室温(25℃)后再开始计时,反应4h后得到1-Boc肼-3-吗啉-2-丙醇,乙酸乙酯萃取,减压蒸馏的方法除去Boc保护的肼和溶剂。In a specific embodiment, 1-morpholine-2,3-epoxypropane and Boc-protected hydrazine can be placed in an ice-water bath respectively according to the ratio, and then ethanol is added respectively, and after the temperature drops to 0 °C, The ice-water bath was removed, and the timer was started after the solution returned to room temperature (25°C). After 4 hours of reaction, 1-Boc hydrazine-3-morpholine-2-propanol was obtained, extracted with ethyl acetate, and the Boc protection was removed by distillation under reduced pressure. hydrazine and solvent.
可参照地,上述合成过程可表示为For reference, the above synthesis process can be expressed as
进一步地,1-吗啉-2,3-环氧丙烷的制备方法可以包括:将1-卤代3-吗啉-2-丙醇与碱反应,1-卤代-3-吗啉-2-丙醇的化学结构式为其中卤素X可以为溴和氯中的任何一种。Further, the preparation method of 1-morpholine-2,3-epoxypropane may include: reacting 1-halogenated 3-morpholine-2-propanol with a base, 1-halogenated-3-morpholine-2 - The chemical structural formula of propanol is Wherein the halogen X can be any one of bromine and chlorine.
可参考地,1-卤代-3-吗啉-2-丙醇与碱反应是在第二溶剂存在的条件下进行,较佳的,第二溶剂例如可以包括THF(四氢呋喃)。此外,第二溶剂还可以包括甲醇,氯仿,或者乙醇等。For reference, the reaction between 1-halo-3-morpholine-2-propanol and a base is carried out in the presence of a second solvent. Preferably, the second solvent may include, for example, THF (tetrahydrofuran). In addition, the second solvent may also include methanol, chloroform, or ethanol or the like.
在一些可选地实施方案中,1-卤代3-吗啉-2-丙醇与碱的摩尔比可以为1:1-5,如1:1、1:2、1:3、1:4或1:5等,也可以为1:1-5范围内的其它比值,优选为1:3。In some alternative embodiments, the molar ratio of 1-halo-3-morpholine-2-propanol to base can be 1:1-5, such as 1:1, 1:2, 1:3, 1:1 4 or 1:5, etc., and other ratios in the range of 1:1-5, preferably 1:3.
在一些可选地实施方案中,1-卤代-3-吗啉-2-丙醇与碱是于15-60℃(如15℃、20℃、30℃、40℃、50℃或60℃等)的条件下反应1-5h(如1h、2h、3h、4h或5h等),优选于40℃的条件下反应4h。In some alternative embodiments, the 1-halo-3-morpholine-2-propanol and base are at 15-60°C (eg, 15°C, 20°C, 30°C, 40°C, 50°C, or 60°C) etc.) for 1-5h (such as 1h, 2h, 3h, 4h or 5h, etc.), preferably at 40°C for 4h.
在一些可选地实施方案中,上述碱可以但不仅限于包括NaOH、KOH、Na2CO3、乙醇钠和叔丁醇钠中的至少一种。In some optional embodiments, the above-mentioned base may include, but is not limited to, at least one of NaOH, KOH, Na 2 CO 3 , sodium ethoxide, and sodium tert-butoxide.
在一些可选地实施方案中,1-卤代-3-吗啉-2-丙醇与碱反应结束后,还包括除去剩余的有机溶剂,例如可采用蒸馏方式除去有机溶剂。In some optional embodiments, after the reaction between 1-halo-3-morpholine-2-propanol and the base is completed, it also includes removing the remaining organic solvent, for example, the organic solvent can be removed by distillation.
在一具体的实施方式中,可以先用四氢呋喃溶解1-卤代3-吗啉-2-丙醇,然后加入乙醇钠,于室温(25℃)反应5h,反应完成后,减压蒸馏。In a specific embodiment, 1-halogenated 3-morpholine-2-propanol can be dissolved in tetrahydrofuran first, then sodium ethoxide is added, and the reaction is carried out at room temperature (25° C.) for 5 hours. After the reaction is completed, distillation under reduced pressure is performed.
可参照地,上述合成过程可表示为其中卤素X可以为溴和氯中的任何一种。For reference, the above synthesis process can be expressed as Wherein the halogen X can be any one of bromine and chlorine.
进一步地,1-卤代-3-吗啉-2-丙醇的制备方法可以包括:将1,3-二卤代-2-丙醇与碱反应,随后再与吗啉进行SN2反应,1,3-二卤-2-丙醇的化学结构式为其中卤素x可以为溴和氯中的任何一种。Further, the preparation method of 1-halo-3-morpholine-2-propanol may include: reacting 1,3-dihalo-2-propanol with a base, and then performing S N2 reaction with morpholine, The chemical structural formula of 1,3-dihalo-2-propanol is Wherein the halogen x can be any one of bromine and chlorine.
在一些可选的实施方案中,可以将1,3-二卤代-2-丙醇与碱混合于第一醇溶液中进行加热反应,随后加入溶解有吗啉的第二醇溶液进行SN2反应。In some optional embodiments, 1,3-dihalo-2-propanol can be mixed with a base in the first alcohol solution for heating reaction, and then the second alcohol solution in which morpholine is dissolved is added to carry out S N2 reaction.
在一些可选地实施方案中,将1,3-二卤代-2-丙醇溶解于第一醇溶液中,随后再加入碱进行加热反应。In some alternative embodiments, 1,3-dihalo-2-propanol is dissolved in the first alcohol solution, followed by addition of a base for heating reaction.
在一些可选地实施方案中,1,3-二卤代-2-丙醇与碱的摩尔比可以为1:2-5,如1:2、1:3、1:4或1:5等,也可以为1:2-5范围内的其它比值,优选为1:3.5。In some alternative embodiments, the molar ratio of 1,3-dihalo-2-propanol to base may be 1:2-5, such as 1:2, 1:3, 1:4 or 1:5 etc., other ratios in the range of 1:2-5 are also possible, preferably 1:3.5.
在一些可选地实施方案中,第一醇溶液可以包括甲醇溶液,第二醇溶液可以包括乙醇溶液。In some alternative embodiments, the first alcoholic solution may include methanol solution, and the second alcoholic solution may include ethanol solution.
在一些可选地实施方案中,加热反应可以于15-60℃(如15℃、20℃、30℃、40℃、50℃或60℃等)的条件下进行1-6h(如1h、2h、3h、4h、5h或6h等),优选于50℃的条件下反应3h。In some optional embodiments, the heating reaction can be carried out under the conditions of 15-60°C (eg 15°C, 20°C, 30°C, 40°C, 50°C or 60°C, etc.) for 1-6h (eg 1h, 2h) , 3h, 4h, 5h or 6h, etc.), preferably at 50°C for 3h.
在一些可选地实施方案中,1,3-二卤代-2-丙醇与吗啉的摩尔比可以为1:1-5,如1:1、1:2、1:3、1:4或1:5等,也可以为1:1-5范围内的其它比值,优选为1:3。In some alternative embodiments, the molar ratio of 1,3-dihalo-2-propanol to morpholine may be 1:1-5, such as 1:1, 1:2, 1:3, 1:1 4 or 1:5, etc., and other ratios in the range of 1:1-5, preferably 1:3.
在一些可选地实施方案中,SN2反应可以于15-60℃(如15℃、20℃、30℃、40℃、50℃或60℃等)的条件下进行2-10h(如2h、4h、5h、6h、8h或10h等),优选于40℃的条件下反应3h。In some optional embodiments, the SN2 reaction can be carried out at 15-60°C (eg, 15°C, 20°C, 30°C, 40°C, 50°C or 60°C, etc.) for 2-10h (eg 2h, 4h, 5h, 6h, 8h or 10h, etc.), preferably at 40°C for 3h.
在一些可选地实施方案中,SN2反应完成后还包括除去剩余的第一醇溶液和第二醇溶液。In some optional embodiments, after the SN2 reaction is completed, it further includes removing the remaining first alcoholic solution and the second alcoholic solution.
在一具体的实施方式中,可以先将1,3-二卤代-2-丙醇溶解于甲醇中,搅拌8min,加入KOH后于室温(25℃)条件下反应5h,再将溶解有吗啉的乙醇溶液加入上述反应体系中,反应5h后减压蒸馏。In a specific embodiment, 1,3-dihalo-2-propanol can be dissolved in methanol first, stirred for 8 minutes, added KOH and reacted at room temperature (25°C) for 5 hours, and then dissolved The ethanolic solution of chlorophyll was added to the above reaction system, and the reaction was carried out for 5 h and then distilled under reduced pressure.
可参照地,上述合成过程可表示为 For reference, the above synthesis process can be expressed as
进一步地,1,3-二卤代-2-丙醇的制备方法可以包括:将丙三醇与三氟乙酸酐、三(二甲胺基)膦(HMPT)和卤化锂类化合物在四氢呋喃溶剂下反应。Further, the preparation method of 1,3-dihalo-2-propanol may include: mixing glycerol with trifluoroacetic anhydride, tris(dimethylamino)phosphine (HMPT) and lithium halide compounds in tetrahydrofuran solvent next reaction.
在一些可选地实施方案中,卤化锂类化合物包括氯化锂或溴化锂中的至少一种。In some optional embodiments, the lithium halide compound includes at least one of lithium chloride or lithium bromide.
在一些可选地实施方案中,丙三醇与所述卤化锂类化合物的摩尔比为1:5-15,如1:5、1:7、1:9、1:11、1:13等,优选为1:10。In some optional embodiments, the molar ratio of glycerol to the lithium halide compound is 1:5-15, such as 1:5, 1:7, 1:9, 1:11, 1:13, etc. , preferably 1:10.
在一些可选地实施方案中,丙三醇置于油浴中,加入所述THF,随后再加入所述三氟乙酸酐、三(二甲胺基)膦(HMPT)和卤化锂类化合物。In some alternative embodiments, glycerol is placed in an oil bath, the THF is added, followed by the trifluoroacetic anhydride, tris(dimethylamino)phosphine (HMPT) and lithium halide compounds.
在一些可选地实施方案中,丙三醇与三氟乙酸酐、三(二甲胺基)膦和卤化锂类化合物于50-100℃的条件下进行5-24h。优选地,丙三醇与三氟乙酸酐、三(二甲胺基)膦和卤化锂类化合物于80℃的条件下进行12h。In some optional embodiments, glycerol and trifluoroacetic anhydride, tris(dimethylamino)phosphine and lithium halide compounds are carried out at 50-100° C. for 5-24 h. Preferably, glycerol and trifluoroacetic anhydride, tris(dimethylamino)phosphine and lithium halide compounds are carried out at 80° C. for 12 h.
在一些可选地实施方案中,丙三醇反应完成后,还包括除去剩余的溶剂,更优地,采用减压蒸馏的方式除去所述溶剂。In some optional embodiments, after the glycerol reaction is completed, it also includes removing the remaining solvent, more preferably, removing the solvent by means of reduced pressure distillation.
可参照地,上述合成过程可表示为 For reference, the above synthesis process can be expressed as
以下结合实施例对本发明的特征和性能作进一步的详细描述。The features and performances of the present invention will be further described in detail below in conjunction with the embodiments.
实施例1Example 1
步骤一:将丙三醇(5g)置于圆底烧瓶溶解于四氢呋喃(30ml)后,加入27.13g三氟乙酸酐,室温条件下搅拌15-30min后,使用旋转蒸发仪除去三氟乙酸。然后加入同样体积的四氢呋喃、HMPT和溴化锂,放入油浴中回流加热3-4小时,利用旋转蒸发仪除去四氢呋喃,加入饱和食盐水,使用乙酸乙酯萃取三次后蒸馏后,得到反应中间产物1,3-二溴-2-丙醇。Step 1: Dissolve glycerol (5g) in tetrahydrofuran (30ml) in a round-bottomed flask, add 27.13g of trifluoroacetic anhydride, stir at room temperature for 15-30min, use a rotary evaporator to remove trifluoroacetic acid. Then add the same volume of tetrahydrofuran, HMPT and lithium bromide, put it into an oil bath and reflux for 3-4 hours, remove tetrahydrofuran by a rotary evaporator, add saturated brine, use ethyl acetate for extraction three times and then distill to obtain a reaction
步骤二:先将反应的产物1,3-二溴-2-丙醇溶解在10mL甲醇中,搅拌10分钟,加入KOH(2.02当量)后,室温反应5h,将吗啉(1.5当量)与10mL乙醇的溶液加入至反应体系中。继续反应5h后,减压蒸馏后得到1-溴代-3-吗啉-2-丙醇。Step 2: Dissolve the
步骤三:取上述反应物中间体1-溴代-3-吗啉-2-丙醇,用10mL四氢呋喃溶解,将乙醇钠(1.1当量)加入至反应瓶中,室温反应5h后,减压蒸馏,得到中间体1-吗啉2,3-环氧丙烷。Step 3: Take the above-mentioned reactant intermediate 1-bromo-3-morpholine-2-propanol, dissolve it with 10 mL of tetrahydrofuran, add sodium ethoxide (1.1 equiv.) into the reaction flask, react at room temperature for 5 h, then distill under reduced pressure , the intermediate 1-morpholine 2,3-epoxypropane was obtained.
步骤四:将上述反应产物1-吗啉2,3-环氧丙烷与Boc肼(3当量)分别置于冰水浴中,分别加入5mL乙醇,待温度降至0℃后,将中间体加入完成后,撤去冰水浴,待溶液恢复至室温后开始计时,反应4h后得到中间体1-Boc肼-3-吗啉-2-丙醇,减压蒸馏除去水合肼及其他溶剂。Step 4: The above reaction products 1-morpholine 2,3-epoxypropane and Boc hydrazine (3 equivalents) were placed in an ice-water bath, respectively, and 5 mL of ethanol was added respectively. After the temperature dropped to 0 °C, the intermediate was added to complete Then, the ice-water bath was removed, and the time was started after the solution returned to room temperature. After 4 hours of reaction, the intermediate 1-Boc hydrazine-3-morpholine-2-propanol was obtained, and the hydrazine hydrate and other solvents were distilled off under reduced pressure.
步骤五:将中间体1-Boc肼-3-吗啉-2-丙醇加入15mL四氢呋喃复溶,用10mL溶解碳酸二乙酯(1.5当量)逐滴加入溶液中。然后升温至70℃后,将溶解于0.5ml甲醇中的甲醇钠溶液(0.1当量),逐滴加入至反应体系中,反应4h。Step 5: The intermediate 1-Boc hydrazine-3-morpholine-2-propanol was added to 15 mL of tetrahydrofuran to redissolve, and 10 mL of dissolved diethyl carbonate (1.5 equivalents) was added dropwise to the solution. Then the temperature was raised to 70° C., sodium methoxide solution (0.1 equivalent) dissolved in 0.5 ml of methanol was added dropwise to the reaction system, and the reaction was carried out for 4 h.
步骤六:将中间体3-Boc肼-5-吗啉基甲基-2-恶唑烷酮加入稀盐酸(2M)和乙酸乙酯室温条件下搅拌6小时后,减压蒸馏得到产物AMOZ。Step 6: The intermediate 3-Boc hydrazine-5-morpholinomethyl-2-oxazolidinone was added to dilute hydrochloric acid (2M) and ethyl acetate, stirred at room temperature for 6 hours, and then distilled under reduced pressure to obtain the product AMOZ.
上述合成路线可参照图1。The above-mentioned synthetic route can refer to Figure 1.
经结构鉴定,所得化合物确为目标产物3-氨基-5-吗啉基甲基-2-恶唑烷酮(AMOZ)。After structural identification, the obtained compound was indeed the target product 3-amino-5-morpholinylmethyl-2-oxazolidinone (AMOZ).
经测定,上述方法的合成产率为8.6%。The synthetic yield of the above method was determined to be 8.6%.
以现有最常用的非一锅法的AMOZ的制备方法为对照组1,现有制备方法制得的AMOZ的合成产率为3.1%。Taking the most commonly used non-one-pot preparation method of AMOZ as
对比实施例1以及对照组可以看出,通过本申请提供的制备方法制备所得的AMOZ的合成产量要高于对照组,说明本申请提供的制备方法能有效提高AMOZ的合成产率。Comparing Example 1 and the control group, it can be seen that the synthetic yield of AMOZ prepared by the preparation method provided by the present application is higher than that of the control group, indicating that the preparation method provided by the present application can effectively improve the synthetic yield of AMOZ.
综上所述,本申请提供的AMOZ的制备方法,操作简单,采用一锅法合成硝基呋喃代谢物AMOZ并通过在制备过程中使用保护基团,极大减少了合成过程的损失,合成产率及回收率较高。To sum up, the preparation method of AMOZ provided by the present application is simple to operate, adopts a one-pot method to synthesize the nitrofuran metabolite AMOZ, and uses a protective group in the preparation process, which greatly reduces the loss of the synthesis process, and the synthetic yield is improved. and recovery rates are high.
以上所述仅为本发明的优选实施方式而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and changes. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010315236.XA CN111333591A (en) | 2020-04-21 | 2020-04-21 | A kind of preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010315236.XA CN111333591A (en) | 2020-04-21 | 2020-04-21 | A kind of preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111333591A true CN111333591A (en) | 2020-06-26 |
Family
ID=71177190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010315236.XA Pending CN111333591A (en) | 2020-04-21 | 2020-04-21 | A kind of preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111333591A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112321576A (en) * | 2020-11-25 | 2021-02-05 | 湖南云科化工有限公司 | Preparation method of triglycidyl isocyanurate |
-
2020
- 2020-04-21 CN CN202010315236.XA patent/CN111333591A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112321576A (en) * | 2020-11-25 | 2021-02-05 | 湖南云科化工有限公司 | Preparation method of triglycidyl isocyanurate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105061230B (en) | Method for preparing dapoxetine hydrochloride | |
CN111333591A (en) | A kind of preparation method of 3-hydrazine-5-morpholinyl methyl-2-oxazolidinone | |
CN104003934B (en) | The synthesis of the fluoro-2-pyridine carboxylic acid of the chloro-3-of 6- | |
CN110981806A (en) | Method for synthesizing aryl pyrazole nitrile and byproduct carbonic acid diester | |
CN110950778A (en) | Process and catalyst system for preparing aromatic malononitrile | |
CN110698352B (en) | A kind of synthetic method of 3-bromo-5-aminocatechol dimethyl ether | |
CN108558686B (en) | A kind of preparation method of bupropion hydrochloride | |
CN112851571A (en) | Preparation method and application of 2- (2, 2,6, 6-tetramethylpiperidine nitroxide radical-4-subunit) acetic acid derivative | |
CN113874351A (en) | Synthetic method of florfenicol | |
CN107629006B (en) | A kind of synthetic method of clotrimazole | |
CN106810546A (en) | A kind of umeclidinium compound | |
CN106117104B (en) | A kind of preparation method of vildagliptin | |
CN111747926B (en) | Improved synthetic process method of topiramate free base | |
CN110498744A (en) | A kind of preparation method of 1-ethyl-3-nitrobenzene | |
CN110452198B (en) | Preparation method of feloxicib | |
CN114790219A (en) | Preparation method of lithium bis (oxalato) borate | |
CN118359560B (en) | Preparation method of methylene blue | |
CN110563643A (en) | synthesis method of (5-bromo-3-methyl-pyridin-2-yl) -methylamine | |
CN102093292A (en) | Method for synthesizing DL-alpha-aminocaprolactam | |
CN107382885A (en) | The preparation method of the triazoles of 1H 1,2,3 | |
CN116283876B (en) | Process for preparing benzopyrone | |
CN103772308B (en) | (preparation method of 1-ethyl-1-methyl-propyl) isoxazole intermediate is with the preparation method of Yi Evil grass amine for 5-amino-3- | |
CN111620875B (en) | Preparation process of imidazopyrazine compound | |
CN103613521A (en) | Water-phase synthetic method of probenecid | |
CN111233864B (en) | Method for industrially producing doxofylline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200626 |